A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Clinical trial NCT00943553 · WITHDRAWN

Trial details

NCT number: NCT00943553
Sponsor: Eisai Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia (AML)

Start date: 2010-06-01
Primary completion: 2011-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.